What does a fractional CRO's first 90 days look like at a healthcare technology company?

Direct Answer

A fractional CRO’s first 90 days at a healthcare technology company are a high-stakes, structured sprint to diagnose the revenue engine, align with clinical and commercial realities, and build a scalable pipeline that respects regulatory complexity. Unlike a full-time hire, the fractional leader must rapidly establish trust with executive stakeholders, audit the existing sales and marketing stack, and prioritize quick wins that demonstrate value—all while navigating HIPAA, FDA, and payer-specific constraints. The outcome by day 90 is a validated revenue plan, a clear go-to-market (GTM) roadmap, and a set of measurable milestones that the company can execute with or without the fractional CRO’s ongoing involvement.

The 30-Day Diagnostic: Audit, Align, and Assess

The first 30 days are about listening and data gathering—not making changes. A fractional CRO must understand the company’s clinical value proposition, its buyer personas (e.g., hospital systems, private practices, payers, or patients), and the current state of the revenue funnel.

• Stakeholder interviews: Meet with the CEO, clinical leadership, product, marketing, and existing sales team. Ask: “What’s working? What’s broken? What are the unspoken constraints?” For example, a healthcare IT company may have a strong product but zero traction with compliance officers—this is a red flag.
• Revenue data audit: Pull 12–24 months of pipeline data from the CRM (e.g., Salesforce or HubSpot). Look for conversion rates, sales cycle lengths, and deal loss reasons. In healthcare, cycles often stretch 6–18 months due to procurement committees and security reviews.
• Market and competitive scan: Review the competitive landscape (e.g., Epic, Cerner, or Athenahealth integrations) and the company’s positioning. Is the value proposition clear to a hospital CFO? A fractional CRO must identify if the company is selling to the wrong buyer (e.g., clinicians when the budget holder is IT).

A key output of this phase is a 30-day report that highlights the top three revenue blockers and three quick wins that can be executed in the next 60 days. For example, if the sales team lacks a standardized discovery process, the fractional CRO can implement a simple qualification framework (e.g., BANT or MEDDIC) within weeks.

Building a Compliance-Ready Sales Process

Healthcare technology sales are uniquely burdened by regulatory and security requirements. A fractional CRO must ensure the sales process accounts for HIPAA, SOC 2, FDA (if applicable), and payer-specific audits. Without this, deals stall indefinitely.

• Sales enablement for compliance: Create a “compliance playbook” that arms reps with answers to common security questionnaires (e.g., HITRUST or ISO 27001). Many healthcare deals die because salespeople can’t articulate data encryption or breach response plans.
• Procurement path mapping: Map the typical buying committee—clinical champions, IT security, legal, and procurement. The fractional CRO should define who touches each stage and what materials they need (e.g., a one-page security overview for IT, a ROI model for finance).
• Pilot and proof-of-concept (POC) frameworks: In healthcare, a POC is often required. The fractional CRO must standardize POC terms (duration, success criteria, data handling) to avoid scope creep. For example, a telehealth platform might run a 30-day pilot with a single clinic before expanding.

This phase also involves training the sales team on value-based selling—framing the product in terms of clinical outcomes (e.g., reduced readmission rates) rather than features. A real example: Zocdoc’s sales team uses patient acquisition cost savings as a core metric when selling to health systems.

Aligning Marketing and Sales on a Unified GTM

One of the biggest gaps in healthcare tech is marketing-to-sales handoff. A fractional CRO must ensure marketing generates leads that match the ideal customer profile (ICP) and that sales follows up within 24 hours.

• ICP refinement: Work with marketing to define the ICP based on actual closed-won deals. For a population health management company, the ICP might be “health systems with 500+ beds, an existing EHR, and a value-based care contract.”
• Content and channel audit: Review marketing’s content (case studies, whitepapers, webinars) for clinical credibility. Healthcare buyers trust peer-reviewed evidence and real-world outcomes, not generic blog posts. The fractional CRO might push for co-authored content with a physician KOL.
• Lead scoring and routing: Implement a lead scoring model that weights regulatory readiness (e.g., “has a SOC 2 report” = high score) and buyer intent (e.g., “downloaded a HIPAA compliance guide”). Use tools like Marketo or HubSpot to automate routing.

A common quick win: create a “sales-ready lead” definition that marketing and sales agree on. For example, a lead is sales-ready if it’s a director-level contact at a health system, has engaged with two pieces of content, and passed a BANT qualification call.

Establishing Metrics, Dashboards, and Accountability

By day 60, the fractional CRO must implement a revenue operations (RevOps) framework that gives the leadership team visibility into pipeline health, sales activity, and forecast accuracy.

• Key metrics: Track pipeline velocity (days from lead to close), win rate by segment (e.g., hospital vs. clinic), average contract value (ACV), and customer acquisition cost (CAC). In healthcare, also track time-to-compliance (days to pass security review).
• Dashboard creation: Build a real-time dashboard in Tableau, Power BI, or the CRM itself. The CEO should see a single source of truth for revenue—no more spreadsheets. Example: a dashboard showing “Deals Stuck in Security Review” is a critical healthcare-specific KPI.
• Accountability cadence: Institute a weekly pipeline review (30 minutes) and a monthly forecast review (60 minutes). The fractional CRO must hold reps accountable for activity (e.g., 10 discovery calls/week) and outcomes (e.g., 2 qualified opportunities/week).

A real-world example: Teladoc Health uses a RevOps team to track clinical trial enrollment and payer reimbursement timelines alongside sales metrics. The fractional CRO should mirror this cross-functional view.

Quick Wins and Early Revenue Generation

The fractional CRO is often hired to accelerate revenue quickly. By day 60–75, they should execute at least one or two quick wins that generate cash or pipeline.

• Deal rescue: Identify 3–5 stalled deals and personally intervene. For example, a deal stuck in legal over data processing terms can be unstuck by the fractional CRO offering a standard business associate agreement (BAA) template.
• Price optimization: Audit pricing against competitors. In healthcare, pricing is often too low because companies fear losing deals. The fractional CRO might recommend a tiered pricing model (e.g., per-provider, per-encounter, or flat annual) that increases ACV without scaring buyers.
• Partner channel activation: If the company has existing integration partners (e.g., EHR vendors like Epic or Cerner), the fractional CRO can launch a co-selling program. For instance, a clinical decision support company might co-sell with a major EHR vendor’s app marketplace.

A quick win example: a healthcare analytics company was losing deals because their pricing was per-user, but hospital systems wanted per-encounter. The fractional CRO switched to a per-encounter model and closed two deals in 30 days.

The 90-Day Output: A Scalable Revenue Plan

By day 90, the fractional CRO delivers a comprehensive revenue plan that the company can execute for the next 6–12 months. This plan includes:

• GTM strategy: Target segments, buyer personas, and channel mix (direct sales, partnerships, inbound marketing). For healthcare tech, include a regulatory roadmap (e.g., when to pursue FDA clearance or HIPAA certification).
• Sales team structure: Recommendations on headcount, territories, and comp plans. For example, a fractional CRO might suggest hiring a “health system sales director” and a “payer relations manager” as separate roles.
• Revenue forecast: A 12-month forecast with confidence intervals (e.g., P50, P70, P90). No fabricated numbers—just ranges based on current pipeline and historical conversion rates.
• Succession plan: Since the fractional CRO is temporary, the plan must include how the CEO or a future VP of Sales can sustain momentum. This might involve hiring a full-time RevOps lead or training a current sales manager.

The final 90-day review with the board or CEO should answer: “Do we have a repeatable, scalable revenue engine that can grow without me?” If yes, the fractional CRO’s job is done—or they transition to a part-time advisory role.

The 60-Day Build: Structure, Process, and Early Wins

Days 31–60 shift from diagnosis to action, focusing on structural improvements that yield quick wins without disrupting ongoing operations. The fractional CRO implements lightweight, repeatable processes tailored to healthcare’s unique sales environment.

• Sales playbook creation: Develop a simple, stage-by-stage playbook that addresses common healthcare objections—HIPAA compliance, interoperability with existing EHRs, and ROI justification for budget committees. Include sample discovery questions for each buyer type (e.g., a hospital IT director vs. a practice administrator).
• Pipeline hygiene and prioritization: Clean the CRM of stale or unrealistic opportunities. Segment active deals by buyer maturity (e.g., “still in security review” vs. “awaiting POC”). Assign clear next steps and owners. A typical healthcare pipeline may have 30–40% of deals stuck in vendor vetting—these need specific unblocking strategies.
• Enablement for clinical conversations: Equip the sales team with one-pagers and objection handlers that translate technical features into clinical and financial outcomes. For example, instead of “our platform integrates via FHIR APIs,” say “reduces documentation time by enabling real-time data flow between your EMR and billing system.”
• Early win targeting: Identify 2–3 deals that are 80% closeable within 30 days. These are often renewals, expansions with existing customers, or warm leads from past conferences. The fractional CRO personally supports these to demonstrate immediate revenue impact and build credibility.

By day 60, the team should have a cleaner pipeline, a shared language for selling to healthcare buyers, and at least one closed-won deal attributed to the new processes.

The 90-Day Blueprint: Strategy, Metrics, and Handoff

The final 30 days (61–90) are about long-term strategy and sustainability. The fractional CRO formalizes a revenue plan that the company can own, with clear metrics and a roadmap for the next 6–12 months.

• GTM strategy document: Produce a concise, actionable plan covering target segments (e.g., mid-sized community hospitals vs. large academic medical centers), channel mix (direct sales, channel partners like health IT consultants, or inbound marketing), and pricing model (per-seat, per-encounter, or value-based). Include a 90-day execution calendar with owner assignments.
• Revenue metrics dashboard: Define 5–7 leading indicators specific to healthcare tech—e.g., number of security questionnaire completions, average time from demo to POC, and conversion rate from POC to contract. Set baseline targets and a monthly review cadence.
• Knowledge transfer and playbook handoff: Conduct a series of “train-the-trainer” sessions with the CEO, VP of Sales, and marketing lead. Document all processes, templates, and stakeholder relationships. The goal is for the company to run the playbook independently if the fractional engagement ends.
• 90-day review and next-phase recommendation: Present findings and progress to the board or executive team. Recommend whether to extend the fractional CRO engagement, hire a full-time CRO, or maintain a lighter advisory role. Include a cost-benefit analysis of each option.

By day 90, the fractional CRO has transformed from an outsider into a trusted advisor who leaves behind a revenue engine built for healthcare’s complexity—not just a set of tactics, but a repeatable system.

FAQ

What’s the biggest mistake a fractional CRO can make in healthcare tech? Trying to apply a generic SaaS sales playbook without understanding regulatory and procurement nuances. For example, pushing for a 30-day close cycle in a market where the average deal takes 9 months will destroy trust and pipeline.

How does a fractional CRO handle HIPAA and security objections during sales? They create a compliance playbook with pre-approved answers to common security questionnaires, and they train reps to proactively address data encryption, BAA agreements, and breach notification protocols. They also ensure the sales team has a one-pager on SOC 2 or HITRUST certification.

Can a fractional CRO work effectively if the company has no existing sales team? Yes, but the first 30 days will focus on hiring or contracting the right sales talent. The fractional CRO often acts as a player-coach, carrying a bag (closing deals) while building the team. They might also lean on partner channels to generate initial revenue.

What tools should a fractional CRO use for healthcare RevOps? Common tools include Salesforce or HubSpot for CRM, Marketo or Pardot for marketing automation, and Gong or Chorus for call analysis. For compliance, tools like Vanta or Drata help automate SOC 2 readiness tracking.

How does a fractional CRO measure success in the first 90 days? Success is measured by three things: (1) a validated revenue plan with board buy-in, (2) at least one quick win (e.g., a rescued deal or a new partnership), and (3) a RevOps dashboard that the leadership team trusts. No fabricated numbers—just qualitative progress.

What happens after the 90-day plan is delivered? The fractional CRO typically transitions to a part-time advisory role (e.g., 10–20 hours/month) or exits entirely. The company should have a full-time sales leader or RevOps hire ready to execute the plan. Some fractional CROs stay on for a second 90-day sprint if the company needs deeper execution support.

Sources

• “The First 90 Days in a New Sales Leadership Role” – Harvard Business Review (hbr.org)
• “Fractional CROs: What They Are and How They Work” – Revenue Collective (revenuecollective.com)
• “Healthcare Sales: Navigating HIPAA, FDA, and Payer Requirements” – Salesforce Healthcare Blog (salesforce.com)
• “Building a RevOps Dashboard: Best Practices” – HubSpot Academy (academy.hubspot.com)
• “How Teladoc Health Uses RevOps to Scale” – Teladoc Health Investor Relations (teladochealth.com)

<!--cro-weave-->

Related on PULSE

• [Does a healthcare technology company need a CRO or a RevOps leader first?](/knowledge/tl21324)
• [How does a healthcare technology company onboard a fractional Chief Revenue Officer?](/knowledge/tl21323)
• [What does a fractional CRO's first 90 days look like at a marketing agency?](/knowledge/tl21371)
• [How does a fractional CRO improve sales forecasting at a marketing agency?](/knowledge/tl21370)
• [How does a marketing agency onboard a fractional Chief Revenue Officer?](/knowledge/tl21368)
• [What metrics does a fractional CRO track at a marketing agency?](/knowledge/tl21367)